标题
Non-human primate models of PD to test novel therapies
作者
关键词
Non-human primate, Parkinson, Levodopa, Dyskinesia, Pharmacotherapy, MPTP
出版物
JOURNAL OF NEURAL TRANSMISSION
Volume 125, Issue 3, Pages 291-324
出版商
Springer Nature
发表日期
2017-04-08
DOI
10.1007/s00702-017-1722-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Parkinson’s disease as a multisystem disorder
- (2017) Lisa Klingelhoefer et al. JOURNAL OF NEURAL TRANSMISSION
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
- (2017) Yvette C Wong et al. NATURE MEDICINE
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
- (2017) Deniz Kirik et al. NEUROBIOLOGY OF DISEASE
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story
- (2017) Yannick Vermeiren et al. NEUROCHEMISTRY INTERNATIONAL
- Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease
- (2017) Janina Borgonovo et al. PARKINSONISM & RELATED DISORDERS
- The Contribution ofα-Synuclein Spreading to Parkinson’s Disease Synaptopathy
- (2017) Francesca Longhena et al. NEURAL PLASTICITY
- Propagation of pathological α-synuclein in marmoset brain
- (2017) Aki Shimozawa et al. Acta Neuropathologica Communications
- The genetic background of Parkinson's disease: current progress and future prospects
- (2016) K. Kalinderi et al. ACTA NEUROLOGICA SCANDINAVICA
- Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients
- (2016) Marc Morissette et al. BIOCHEMICAL PHARMACOLOGY
- Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys
- (2016) Elisa Garbayo et al. BIOMATERIALS
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease
- (2016) Cécile Moro et al. BRAIN RESEARCH
- Induced pluripotent stem cells and Parkinson's disease: modelling and treatment
- (2016) Xiaoyun Xu et al. CELL PROLIFERATION
- Connectivity Changes in Parkinson’s Disease
- (2016) Antonio Cerasa et al. Current Neurology and Neuroscience Reports
- Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease
- (2016) Manale Bensaid et al. EXPERIMENTAL NEUROLOGY
- Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration
- (2016) Santiago Perez-Lloret et al. EXPERT OPINION ON PHARMACOTHERAPY
- New and emerging medical therapies in Parkinson’s disease
- (2016) Mitesh Lotia et al. EXPERT OPINION ON PHARMACOTHERAPY
- Retrograde transport of neurotrophic factor signaling: implications in neuronal development and pathogenesis
- (2016) Keisuke Ito et al. JOURNAL OF BIOCHEMISTRY
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Current and experimental treatments of Parkinson disease: A guide for neuroscientists
- (2016) Wolfgang Oertel et al. JOURNAL OF NEUROCHEMISTRY
- Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
- (2016) Bin Xiao et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms
- (2016) Benedicte Ballanger et al. JOURNAL OF NEUROSCIENCE
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Nonmotor features of Parkinson's disease subtypes
- (2016) Connie Marras et al. MOVEMENT DISORDERS
- The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations
- (2016) Raul Martínez-Fernández et al. MOVEMENT DISORDERS
- Opportunities and challenges in modeling human brain disorders in transgenic primates
- (2016) Charles G Jennings et al. NATURE NEUROSCIENCE
- Advances in markers of prodromal Parkinson disease
- (2016) Ronald B. Postuma et al. Nature Reviews Neurology
- Evolving basic, pathological and clinical concepts in PD
- (2016) Lorraine V. Kalia et al. Nature Reviews Neurology
- Review: Sporadic Parkinson's disease: development and distribution ofα-synuclein pathology
- (2016) K. Del Tredici et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models
- (2016) Wai Kin D. Ko et al. NEUROPHARMACOLOGY
- Do patients with late-stage Parkinson's disease still respond to levodopa?
- (2016) Margherita Fabbri et al. PARKINSONISM & RELATED DISORDERS
- Non motor subtypes and Parkinson's disease
- (2016) Anna Sauerbier et al. PARKINSONISM & RELATED DISORDERS
- Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease
- (2016) Douglas A. Grow et al. Stem Cell Research
- Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
- (2016) Janina Grosch et al. Frontiers in Cellular Neuroscience
- Generation of transgenic cynomolgus monkeys that express green fluorescent protein throughout the whole body
- (2016) Yasunari Seita et al. Scientific Reports
- A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects
- (2016) Yan Shen et al. Frontiers in Aging Neuroscience
- Retrograde Axonal Degeneration in Parkinson Disease
- (2016) Patricia Tagliaferro et al. Journal of Parkinsons Disease
- Is Axonal Degeneration a Key Early Event in Parkinson’s Disease?
- (2016) Zuzanna Kurowska et al. Journal of Parkinsons Disease
- Near-infrared light treatment reduces astrogliosis in MPTP-treated monkeys
- (2016) Nabil El Massri et al. EXPERIMENTAL BRAIN RESEARCH
- Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease
- (2016) Patrick Hickey et al. Frontiers in Neuroscience
- Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease
- (2016) Daniel M. Johnstone et al. Frontiers in Neuroscience
- Evaluation of Models of Parkinson's Disease
- (2016) Shail A. Jagmag et al. Frontiers in Neuroscience
- Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
- (2016) Timothy J. Collier et al. Frontiers in Neuroscience
- Near-infrared light is neuroprotective in a monkey model of Parkinson disease
- (2015) Fannie Darlot et al. ANNALS OF NEUROLOGY
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Characterization of long-term motor deficits in the 6-OHDA model of Parkinson's disease in the common marmoset
- (2015) M. Santana et al. BEHAVIOURAL BRAIN RESEARCH
- A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion
- (2015) Jordi Boix et al. BEHAVIOURAL BRAIN RESEARCH
- Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson’s Disease
- (2015) Penelope J. Hallett et al. Cell Stem Cell
- Current disease modifying approaches to treat Parkinson’s disease
- (2015) Dan Lindholm et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
- (2015) Tomoyoshi Kondo et al. CLINICAL NEUROPHARMACOLOGY
- Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non-motor subtypes
- (2015) P. Zis et al. EUROPEAN JOURNAL OF NEUROLOGY
- Translational research for Parkinson׳s disease: The value of pre-clinical primate models
- (2015) Romina Aron Badin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review
- (2015) Michael D. Staudt et al. GERONTOLOGY
- Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9
- (2015) Yongchang Chen et al. HUMAN MOLECULAR GENETICS
- Neuropathobiology of non-motor symptoms in Parkinson disease
- (2015) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Modulation of motor cortex neuronal activity and motor behavior during subthalamic nucleus stimulation in the normal primate
- (2015) Luke A. Johnson et al. JOURNAL OF NEUROPHYSIOLOGY
- α-Synuclein and nonhuman primate models of Parkinson's disease
- (2015) Scott C. Vermilyea et al. JOURNAL OF NEUROSCIENCE METHODS
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Cell-based therapies for Parkinson disease—past insights and future potential
- (2015) Roger A. Barker et al. Nature Reviews Neurology
- Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
- (2015) R.T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Brains, Genes, and Primates
- (2015) Juan Carlos Izpisua Belmonte et al. NEURON
- Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications
- (2015) Nicolas Morin et al. NEUROPHARMACOLOGY
- The highly-selective 5-HT1A agonist F15599 reduces l-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque
- (2015) Philippe Huot et al. NEUROPHARMACOLOGY
- Early Changes in Saccadic Eye Movement in Hemiparkinsonian MPTP-Treated Monkeys
- (2015) Leonid V. Tereshchenko et al. PERCEPTION
- Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys
- (2015) Nicolas Morin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Subject-specific computational modeling of DBS in the PPTg area
- (2015) Laura M. Zitella et al. Frontiers in Computational Neuroscience
- Early Parkinson's disease symptoms in -synuclein transgenic monkeys
- (2015) Y. Niu et al. HUMAN MOLECULAR GENETICS
- Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates
- (2014) Laura L. Dugan et al. ANNALS OF NEUROLOGY
- Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson’s Disease
- (2014) Susan H. Fox et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
- (2014) Yuyu Niu et al. CELL
- TALEN-Mediated Gene Mutagenesis in Rhesus and Cynomolgus Monkeys
- (2014) Hailiang Liu et al. Cell Stem Cell
- Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia
- (2014) Michel Engeln et al. CEREBRAL CORTEX
- Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
- (2014) Annalisa Pinna CNS DRUGS
- Sleep Disorders in Parkinsonian Macaques: Effects of L-Dopa Treatment and Pedunculopontine Nucleus Lesion
- (2014) H. Belaid et al. JOURNAL OF NEUROSCIENCE
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy)
- (2014) Claustre Pont-Sunyer et al. MOVEMENT DISORDERS
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
- (2014) Daniela Berg et al. MOVEMENT DISORDERS
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys
- (2014) Thérèse Di Paolo et al. PARKINSONISM & RELATED DISORDERS
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- l-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model
- (2014) Kiyoshi Ando et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Alteration of Daily and Circadian Rhythms following Dopamine Depletion in MPTP Treated Non-Human Primates
- (2014) Karim Fifel et al. PLoS One
- Cardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman Primates
- (2014) Valerie Joers et al. PLoS One
- Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease
- (2014) Abdelhamid Benazzouz et al. Frontiers in Aging Neuroscience
- Istradefylline: First Global Approval
- (2013) Rosselle Dungo et al. DRUGS
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- Modeling dyskinesia in animal models of Parkinson disease
- (2013) Nicolas Morin et al. EXPERIMENTAL NEUROLOGY
- Modeling Parkinson's disease in monkeys for translational studies, a critical analysis
- (2013) Lisa F. Potts et al. EXPERIMENTAL NEUROLOGY
- Using viral-mediated gene delivery to model Parkinson's disease: Do nonhuman primate investigations expand our understanding?
- (2013) Massimo S. Fiandaca et al. EXPERIMENTAL NEUROLOGY
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- Long-distance retrograde neurotrophic factor signalling in neurons
- (2013) Anthony W. Harrington et al. NATURE REVIEWS NEUROSCIENCE
- Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation
- (2013) Robert Rosenbaum et al. NEUROBIOLOGY OF DISEASE
- Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in l-DOPA-treated parkinsonian monkeys
- (2013) Nicolas Morin et al. NEUROPHARMACOLOGY
- TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque
- (2013) Tom H. Johnston et al. NEUROPHARMACOLOGY
- Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
- (2013) Andreas Puschmann PARKINSONISM & RELATED DISORDERS
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients
- (2013) Roberto Erro et al. PLoS One
- Improved Cell Therapy Protocols for Parkinson's Disease Based on Differentiation Efficiency and Safety of hESC-, hiPSC-, and Non-Human Primate iPSC-Derived Dopaminergic Neurons
- (2013) Maria Sundberg et al. STEM CELLS
- Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate Brain
- (2013) Marina E. Emborg et al. Cell Reports
- Modeling Parkinson's Disease in Primates: The MPTP Model
- (2013) G. Porras et al. Cold Spring Harbor Perspectives in Medicine
- Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate
- (2013) Asuka Morizane et al. Stem Cell Reports
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease
- (2012) Alastair J. Noyce et al. ANNALS OF NEUROLOGY
- Axonal degeneration as a therapeutic target in the CNS
- (2012) Paul Lingor et al. CELL AND TISSUE RESEARCH
- AAV2-neurturin (CERE-120) for Parkinson's disease
- (2012) Patrick Hickey et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy
- (2012) Vincent A. Jourdain et al. JOURNAL OF NEUROSURGERY
- Istradefylline, an adenosine A2A receptor antagonist, for patients with Parkinson's Disease: A meta-analysis
- (2012) Wanqiang Chen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A critique of available scales and presentation of the non-human primate dyskinesia rating scale
- (2012) Susan H. Fox et al. MOVEMENT DISORDERS
- Premotor Parkinson's disease: Concepts and definitions
- (2012) Andrew Siderowf et al. MOVEMENT DISORDERS
- Effect of chronic l-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain
- (2012) Golnasim Riahi et al. NEUROCHEMISTRY INTERNATIONAL
- l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease
- (2012) Philippe Huot et al. NEUROPHARMACOLOGY
- MPEP, an mGlu5 receptor antagonist, reduces the development of l-DOPA-induced motor complications in de novo parkinsonian monkeys: Biochemical correlates
- (2012) Nicolas Morin et al. NEUROPHARMACOLOGY
- Animal models of l-DOPA–induced dyskinesia: an update on the current options
- (2012) H. Iderberg et al. NEUROSCIENCE
- Dyskinetic patients show rebound worsening of affect after an acute L-dopa challenge
- (2012) Andrew H. Evans et al. PARKINSONISM & RELATED DISORDERS
- Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts
- (2012) M. Politis et al. Science Translational Medicine
- Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
- (2012) Yoichi Imaizumi et al. Molecular Brain
- History, Applications, and Mechanisms of Deep Brain Stimulation
- (2012) Svjetlana Miocinovic et al. JAMA Neurology
- Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
- (2011) G. J. Masilamoni et al. BRAIN
- The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias
- (2011) Christopher A. Lieu et al. BRAIN RESEARCH BULLETIN
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias
- (2011) Golnasim Riahi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Pallidal stimulation: Effect of pattern and rate on bradykinesia in the non-human primate model of Parkinson's disease
- (2011) Kenneth B. Baker et al. EXPERIMENTAL NEUROLOGY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- The selective mu-opioid receptor antagonist adl5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease
- (2011) James B. Koprich et al. MOVEMENT DISORDERS
- The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease
- (2011) Alexandra Gaenslen et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
- (2011) Kurt A. Jellinger MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease
- (2011) Sonja Kriks et al. NATURE
- Use of viral vectors to create animal models for Parkinson's disease
- (2011) Karin Löw et al. NEUROBIOLOGY OF DISEASE
- Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model
- (2011) Peternella S. Verhave et al. NEUROPHARMACOLOGY
- The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys
- (2011) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Early Presymptomatic and Long-Term Changes of Rest Activity Cycles and Cognitive Behavior in a MPTP-Monkey Model of Parkinson's Disease
- (2011) Julien Vezoli et al. PLoS One
- The serotonergic system in Parkinson's disease
- (2011) Philippe Huot et al. PROGRESS IN NEUROBIOLOGY
- REM Sleep Behavior Disorder in the Marmoset MPTP Model of Early Parkinson Disease
- (2011) Peternella S. Verhave et al. SLEEP
- MAO-inhibitors in Parkinson's Disease
- (2011) Peter Riederer et al. Experimental Neurobiology
- Functional models of Parkinson's disease: A valuable tool in the development of novel therapies
- (2010) Peter Jenner ANNALS OF NEUROLOGY
- Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
- (2010) Daniella Rylander et al. ANNALS OF NEUROLOGY
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Tyrosine hydroxylase and regulation of dopamine synthesis
- (2010) S. Colette Daubner et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The cholinergic system and Parkinson disease
- (2010) Nicolaas I. Bohnen et al. BEHAVIOURAL BRAIN RESEARCH
- Cortical Regulation of Striatal Medium Spiny Neuron Dendritic Remodeling in Parkinsonism: Modulation of Glutamate Release Reverses Dopamine Depletion–Induced Dendritic Spine Loss
- (2010) Bonnie G. Garcia et al. CEREBRAL CORTEX
- Dissociation of motor symptoms during deep brain stimulation of the subthalamic nucleus in the region of the internal capsule
- (2010) Weidong Xu et al. EXPERIMENTAL NEUROLOGY
- Effect of l-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
- (2010) Bazoumana Ouattara et al. JOURNAL OF NEUROCHEMISTRY
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
- (2010) Jia-Yi Li et al. MOVEMENT DISORDERS
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future
- (2010) Anthony E Lang NATURE MEDICINE
- Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells
- (2010) Trond Aasen et al. Nature Protocols
- 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
- (2010) Philippe Huot et al. NEUROBIOLOGY OF AGING
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
- (2010) Daniella Rylander et al. NEUROBIOLOGY OF DISEASE
- Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
- (2010) Nicolas Morin et al. NEUROPHARMACOLOGY
- Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
- (2010) B. Ouattara et al. NEUROSCIENCE
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
- (2010) Kenneth A. Follett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transgenic rhesus monkeys produced by gene transfer into early-cleavage–stage embryos using a simian immunodeficiency virus-based vector
- (2010) Yuyu Niu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease
- (2010) M. R. Ahmed et al. Science Translational Medicine
- Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial
- (2009) Michael S. Okun et al. ANNALS OF NEUROLOGY
- Generation of induced pluripotent stem cells from human blood
- (2009) Y.-H. Loh et al. BLOOD
- Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model
- (2009) E. Decamp et al. BRAIN RESEARCH
- Generation of Induced Pluripotent Stem Cells from Human Cord Blood
- (2009) Alexandra Haase et al. Cell Stem Cell
- Levodopa-related wearing-off in Parkinson's disease: identification and management
- (2009) Rajesh Pahwa et al. CURRENT MEDICAL RESEARCH AND OPINION
- Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
- (2009) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
- (2009) Quentin Barraud et al. EXPERIMENTAL NEUROLOGY
- Neuroprotective actions of sex steroids in Parkinson’s disease
- (2009) Mélanie Bourque et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
- (2009) Jamie L. Eberling et al. HUMAN GENE THERAPY
- Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
- (2009) Louisa C. Johnston et al. HUMAN GENE THERAPY
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells
- (2009) J. Utikal et al. JOURNAL OF CELL SCIENCE
- Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model
- (2009) Xin Yang et al. JOURNAL OF GENE MEDICINE
- Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months
- (2009) L Alvarez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathologic Modifications of α-Synuclein in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Squirrel Monkeys
- (2009) Alison L. McCormack et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- An objective measurement of locomotion behavior for hemiparkinsonian cynomolgus monkeys
- (2009) N. Liu et al. JOURNAL OF NEUROSCIENCE METHODS
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- Diffusion tensor and perfusion MRI of non-human primates
- (2009) Timothy Q. Duong METHODS
- No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
- (2009) Glenda Halliday et al. MOVEMENT DISORDERS
- Generation of transgenic non-human primates with germline transmission
- (2009) Erika Sasaki et al. NATURE
- Medical Treatment of Parkinson Disease
- (2009) Mark Stacy NEUROLOGIC CLINICS
- Course in Parkinson disease subtypes: A 39-year clinicopathologic study
- (2009) A. H. Rajput et al. NEUROLOGY
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: Common implication of striatal neuropeptides
- (2009) Mohamed Khalil Tamim et al. NEUROPHARMACOLOGY
- EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
- (2009) Christopher D. Herzog et al. NEUROSURGERY
- Neuroprotection in Parkinson's disease
- (2009) Anthony H.V. Schapira PARKINSONISM & RELATED DISORDERS
- Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
- (2009) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Thalamic changes in Parkinson's disease
- (2009) Glenda M. Halliday PARKINSONISM & RELATED DISORDERS
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
- A critical evaluation of the Braak staging scheme for Parkinson's disease
- (2008) Robert E. Burke et al. ANNALS OF NEUROLOGY
- Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations
- (2008) Olivier Rascol ARCHIVES OF NEUROLOGY
- Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
- (2008) Gilbert Bensimon et al. BRAIN
- Enhancing Aromatic L-amino Acid Decarboxylase Activity: Implications for L-DOPA Treatment in Parkinson's Disease
- (2008) Maria Hadjiconstantinou et al. CNS Neuroscience & Therapeutics
- Dopamine agonists in Parkinson’s disease - focus on non-motor symptoms
- (2008) P. Jenner EUROPEAN JOURNAL OF NEUROLOGY
- Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets
- (2008) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Implication of NMDA Receptors in the Antidyskinetic Activity of Cabergoline, CI-1041, and Ro 61-8048 in MPTP Monkeys with Levodopa-induced Dyskinesias
- (2008) Bazoumana Ouattara et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Dynamic Changes in the Cortex-Basal Ganglia Network After Dopamine Depletion in the Rat
- (2008) Cyril Dejean et al. JOURNAL OF NEUROPHYSIOLOGY
- Parkinsonian Beta Oscillations in the External Globus Pallidus and Their Relationship with Subthalamic Nucleus Activity
- (2008) N. Mallet et al. JOURNAL OF NEUROSCIENCE
- Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task
- (2008) Aurelio Campos-Romo et al. JOURNAL OF NEUROSCIENCE METHODS
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
- (2008) Christopher D Herzog et al. MOLECULAR THERAPY
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Towards a transgenic model of Huntington’s disease in a non-human primate
- (2008) Shang-Hsun Yang et al. NATURE
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism
- (2008) t. chaumette et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Invited Article: Nervous system pathology in sporadic Parkinson disease
- (2008) H. Braak et al. NEUROLOGY
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Lewy body pathology in long-term fetal nigral transplants: is parkinson's disease transmitted from one neural system to another?
- (2008) Jeffrey H Kordower et al. NEUROPSYCHOPHARMACOLOGY
- The 6-hydroxydopamine model: News from the past
- (2008) Fabio Blandini et al. PARKINSONISM & RELATED DISORDERS
- The association between motor subtypes and psychopathology in Parkinson's disease
- (2008) J.S.A.M. Reijnders et al. PARKINSONISM & RELATED DISORDERS
- Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
- (2007) L GREGOIRE et al. BEHAVIOURAL BRAIN RESEARCH
- Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease
- (2007) M. Bousquet et al. FASEB JOURNAL
- mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys
- (2007) Pershia Samadi et al. NEUROBIOLOGY OF AGING
- Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s disease
- (2007) D.E. Redmond et al. NEUROBIOLOGY OF DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started